New Key Statistics Module, Z-Score and F-Score
NAS:BMRN Key Ratios
| Market Cap $ M | 15,354.82 |
| Enterprise Value $ M | 15,396.20 |
| P/E(ttm) | 75.62 |
| PE Ratio without NRI | 42.41 |
| Forward PE Ratio | 30.40 |
| Price/Book | 3.03 |
| Price/Sales | 6.33 |
| Price/Free Cash Flow | 95.64 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,471.00 |
| EPS (TTM) $ | 1.07 |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 86.10 |
| EV-to-EBIT | 60.63 |
| EV-to-EBITDA | 42.86 |
| PEG | -- |
| Shares Outstanding M | 189.78 |
| Net Margin (%) | 8.31 |
| Operating Margin % | 7.17 |
| Pre-tax Margin (%) | 9.60 |
| Quick Ratio | 1.70 |
| Current Ratio | 2.74 |
| ROA % (ttm) | 3.07 |
| ROE % (ttm) | 4.22 |
| ROIC % (ttm) | 3.01 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.83 |
BMRN Number of Guru Trades
BMRN Volume of Guru Trades
Gurus Latest Trades with NAS:BMRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BMRN is held by these investors
Total 5
Biomarin Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:BMRN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers